KYNB 8-K 2026-08-31

KYNTRA BIO, INC. (KYNB) 8-K dated 2026-08-31 — accession 0001193125-26-377059.

KYNTRA BIO, INC. (KYNB) common stock.

KYNTRA BIO, INC. filed a 8-K on 2026-08-31. Accession 0001193125-26-377059.

This 8-K covers: Material agreement (Item 1.01), New debt obligation (Item 2.03), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported KYNB revenue for 2025-12-31 was $6.4M. Net income was $183.5M. Revenue was down 95.6% from 2023-12-31 to 2025-12-31.

Not investment advice. The KYNB SEC hub lists recent forms. The stock page is the research view.